NTRR Hires Experienced Exec to Spearhead New Research and Development
NTRR Hires Experienced Exec to Spearhead New Research and Development
SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that it has hired a an experienced executive to spearhead the company's new research and development projects in the $42 billion nutraceuticals industry—including projects targeting the booming $1.7 billion medical cannabis sector.
For the more than 30 years, Dr. Richard C. Kaufman has served as an executive nutraceuticals product developer and researcher. He holds a Ph. D. in Bio-Nutritional Chemistry as well as patents on advanced nutraceutical delivery systems, and his work has been published in a number of scientific journals.
At NTRR, he will lead the company's efforts to develop and market the next generation of custom nutraceutical delivery systems—particularly those engineered to improve products and services in the booming U.S. MMJ market.
"Dr. Kaufman's extensive experience in nutraceutical product development makes him the ideal candidate to lead our efforts in this new space," said NTRR CEO Sydney Jim. "We expect that his contributions as a developer and consultant will prove invaluable as we work to build Neutra Corp. into a natural-wellness powerhouse that delivers big returns to both patients and our investors."
By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR's initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS:
The article NTRR Hires Experienced Exec to Spearhead New Research and Development originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
